Omelia 40 mg/5 mg/25 mg filmom obložene tablete
| Name | Omelia 40 mg/5 mg/25 mg filmom obložene tablete |
|---|---|
| Marketing Authorisation Number | HR-H-535063194 |
| Active Substance | olmesartanmedoksomil amlodipinbesilat hidroklorotiazid |
| Composition | jedna filmom obložena tableta sadrži 40 mg olmesartanmedoksomila, 5 mg amlodipina (u obliku amlodipinbesilata) i 25 mg hidroklorotiazida |
| Pharmaceutical Form | filmom obložena tableta |
| Manufacturer | STADA Arzneimittel AG, Bad Vilbel, Njemačka Clonmel Healthcare Ltd., Clonmel, Co. Tipperary, Irska |
| Marketing Authorisation Holder | Stada d.o.o., Hercegovačka 14, Zagreb, Hrvatska |
| Marketing Authorisation Date | 18.05.2020 |
| MA Period of Validity | 18.05.2025 |
| Classification Number | UP/I-530-09/18-01/296 |
| Registration Number | 381-12-01/30-20-02 |
| Prescription | na recept |
| Type of prescription | ponovljivi recept |
| Distribution | u ljekarni |
| Advertising to general public | zabranjeno |
| ATC Code | C09DX03 |
| Medicinal product marketed in the Croatia | Da |
| SmPC | download |
| PL | download |
| Public Assessment Report | download |
